Form 4: Inotiv Director Mary Theresa Coelho Receives Stock Grant

Director Mary Theresa Coelho received a grant of 39,392 restricted stock units in Inotiv, Inc.

Summary

• On March 14, 2025, Mary Theresa Coelho, a director of Inotiv, Inc., acquired 39,392 shares of common stock through a grant of restricted stock units.
• The price of the acquired stock was $0.
• Following the transaction, Coelho directly owns 79,803 shares of Inotiv, Inc.
• The restricted stock units vest in full on March 14, 2026, or immediately prior to the next annual meeting of stockholders if stepping down from the Board.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The stock grant is a standard practice and indicates confidence in the company's future.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.

Future Outlook

The vesting of the restricted stock units on March 14, 2026, incentivizes the director to remain with the company and contribute to its success.

Industry Context

Stock grants are a common form of executive compensation in the biotech industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.

Key Dates